Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis

By afschroeder • March 12, 2026

Silverberg JI, Bieber T, Eyerich K, Armstrong AW, Nickoloff BJ, Natalie CR, Gallo G, Okragly A, Wolf E, Xu C, Moser BA, Rueda MJ, Elmaraghy H, Uluckan O, Gudjonsson JE. Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis. J Dermatolog Treat. 2026 Dec;37(1):2636417. doi: 10.1080/09546634.2026.2636417. Epub 2026 Mar 12. PMID: 41814992.

Tags: atopic dermatitis, Dermatology, EASI 90, lebrikizumab, Publications, remission

The liver regulates ectopic calcification in Abcc6-deficient models of Pseudoxanthoma Elasticum

Wang Y, Sun B, Ma F, Tao B, Gu Y, Zhou Z, Kim J, Zhang L, Liu Z, Ten Hoeve J, Stiles L, Fernandez-Del-Rio L,[...]

GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study

Ma EJ, Roberts AM, Jeong CY, Chou P, Katz A, Nong Y, Johnsen N, Yan M, Ochoa MT, Armstrong AW. GLP-1RAs and cardiovascular risk reduction[...]

Ethical considerations regarding environmental impact of generative artificial intelligence (AI) in dermatology

Ebriani J, Yan MJ, Lester J, Farshchian M, Wongvibulsin S. Ethical considerations regarding environmental impact of generative artificial intelligence (AI) in dermatology. J Am Acad[...]